Search Results 441-450 of 2452 for 2024embarking
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The secondary objective is to evaluate the pharmacokinectics or movement of drug throughout the body (PK) of BIIB078 in participants with C9ORF72-ALS.
The purpose of this study is to evaluate whether the combination of durvalumab plus lurbinectedin can increase 6 month progression-free survival, in patients ...
The purpose of this study is to improve cost-efficiency of microsurgical reconstruction by using flap-monitoring devices only when the surgeon believes that the ...
A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R ...
Methylated DNA Markers (MDMs) and copy number alterations have been discovered and biologically validated in esophageal brushings and swallowed cell collection ...
The purpose of this study is to demonstrate superior efficacy on ataxic manifestations with oral nizubaglustat dosing compared with placebo when administered ...
Fredric Meyer, M.D.. Juanita Kious Waugh Executive Dean of Education, Mayo Clinic College of Medicine and Science. Dean, Mayo Clinic Alix School of Medicine.
Precision medicine is rapidly transforming modern healthcare. It's a personalized approach that tailors prevention and treatment to each individual — moving ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.